Endo Pharmaceuticals Holdings Inc. (ENDP) announced the appointment of Julie McHugh as chief operating officer, effective March 15.
Most recently, McHugh was president and CEO for Nora Therapeutics. Before joining Nora, she held senior positions at Johnson & Johnson during a twelve year period. Her last role at J&J was Company Group Chairman for the Global Virology Business Unit. Before that she was President of Centocor, Inc., a J&J company.
For comments and feedback: editorial@rttnews.com